May 2008
Sun Mon Tue Wed Thu Fri Sat
        1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

Authors' Committee

Chair:

Andy Eggers (Gov)

Members:

Weihua An (Soc)
Kevin Bartz (Stats)
Sebastian Bauhoff (HealthPol)
John Graves (HealthPol)
Justin Grimmer (Gov)
Jens Hainmueller (Gov)
Mike Kellermann (Gov)
Ellie Powell (Gov)
Gary King (Gov)

Weekly Research Workshop Sponsors

Alberto Abadie, Lee Fleming, Adam Glynn, Guido Imbens, Gary King, Kevin Quinn, Jamie Robins, Don Rubin, Chris Winship

Recent Comments

Recent Entries

Categories

Blogroll

Brad DeLong
Cognitive Daily
Complexity & Social Networks
Developing Intelligence
EconLog
The Education Wonks
Empirical Legal Studies
Free Exchange
Freakonomics
Health Care Economist
Junk Charts
Language Log
Law & Econ Prof Blog
Machine Learning (Theory)
Marginal Revolution
Mixing Memory
Mystery Pollster
New Economist
Political Arithmetik
Political Science Methods
Pure Pedantry
Science & Law Blog
Simon Jackman
Social Science++
Statistical modeling, causal inference, and social science

Archives

Notification

Powered by
Movable Type 3.34


« Google Charts from R: Maps | Main | Linguistics of the Debate »

16 April 2008

JAMA article on ghostwriting medical studies

The Journal of the American Medical Association published a piece today on ghostwriting of medical research. Thanks to the Vioxx lawsuits, the authors say that they found documents ``describing Merck employees working either independently or in collaboration with medical publishing companies to prepare manuscripts and subsequently recruiting external, academically affiliated investigators to be authors. Recruited authors were frequently placed in the first and second positions of the authorship list.’’ One of the exhibits uses a placeholder ``External author?’’ for the expert to be named. Obviously the idea that a pharmaceutical company is pre-writing clinical studies is as controversial as doctors possibly signing off on them without really being involved. A NYT article has some comments, and Merck has released a press statement.


Ross, J et al (2008) "Guest Authorship and Ghostwriting in Publications Related to Rofecoxib. A Case Study of Industry Documents From Rofecoxib Litigation" JAMA 299(15):1800-1812.

Posted by Sebastian Bauhoff at April 16, 2008 10:54 PM

Comments

Notification

Enter e-mail address to receive notification of new comments to this entry

Post a comment




Remember Me?

(you may use HTML tags for style)